Mumbai, July 11 -- Gland Pharma announced that the Pashamylaram facility of the Company has received certificate of Good Manufacturing Practices (GMP) Compliance from Danish Medicines Agency in connection with Marketing

authorizations listing manufacturers located outside of the European Economic Area, for aseptically prepared Powder for injection, infusion and inhalation.

Published by HT Digital Content Services with permission from Capital Market....